LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

Search

Cencora Inc

Gesloten

SectorGezondheidszorg

327.42 -1.36

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

325.86

Max

330.35

Belangrijke statistieken

By Trading Economics

Inkomsten

906M

566M

Verkoop

2.2B

86B

K/W

Sectorgemiddelde

41.472

57.833

EPS

4.08

Dividendrendement

0.64

Winstmarge

0.659

Werknemers

47,000

EBITDA

858M

1B

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+25.86% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.64%

2.47%

Volgende Winsten

6 mei 2026

Volgende dividenddatum

1 jun 2026

Volgende Ex Dividend datum

15 mei 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-3.4B

67B

Vorige openingsprijs

328.78

Vorige sluitingsprijs

327.42

Nieuwssentiment

By Acuity

50%

50%

147 / 350 Rangschikking in Healthcare

Cencora Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 mrt 2026, 23:50 UTC

Marktinformatie

Global Equities Roundup: Market Talk

22 mrt 2026, 23:50 UTC

Marktinformatie

LG Electronics Set to Stage Strong Earnings Rebound in 1Q -- Market Talk

22 mrt 2026, 23:49 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Gold Edges Lower on Prospects of Liquidity-Driven Sales -- Market Talk

22 mrt 2026, 23:49 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Nikkei May Fall as Concerns About Middle East Conflict Persist -- Market Talk

22 mrt 2026, 23:49 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Global Forex and Fixed Income Roundup: Market Talk

22 mrt 2026, 23:41 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Oil Edges Lower as Traders Eye Trump's Deadline to Reopen Strait of Hormuz -- Market Talk

22 mrt 2026, 22:57 UTC

Acquisities, Fusies, Overnames

Perseus Mining: Location of Aurum's Discoveries Present Potential Future Synergies

22 mrt 2026, 22:56 UTC

Acquisities, Fusies, Overnames

Perseus Mining: Aurum Share Acquisition Cost A$23.69 Million

22 mrt 2026, 22:56 UTC

Acquisities, Fusies, Overnames

Perseus Mining: Aurum's Boundiali Gold Project Located to South of Sissingue Gold Mine

22 mrt 2026, 22:55 UTC

Acquisities, Fusies, Overnames

Perseus Mining: Participated in Aurum Resources Equity Raising

22 mrt 2026, 22:54 UTC

Acquisities, Fusies, Overnames

Perseus Mining: Acquires 9.9% Interest in Aurum Resources

22 mrt 2026, 22:22 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

After Selloff, Gold Seen Supported by Strait of Hormuz Deadline -- Market Talk

22 mrt 2026, 22:06 UTC

Acquisities, Fusies, Overnames

Synopsys Has Market Value Over $80 Billion; Major Customers Include Nvidia -- WSJ

22 mrt 2026, 22:06 UTC

Acquisities, Fusies, Overnames

Activist Elliott Builds Big Stake in Chip-Design Software Maker Synopsys -- WSJ

22 mrt 2026, 22:06 UTC

Acquisities, Fusies, Overnames

Activist Elliott Investment Management Has Multibillion-Dollar Investment in Synopsys, Sources Say -- WSJ

22 mrt 2026, 22:06 UTC

Acquisities, Fusies, Overnames

Elliott Plans to Push Synopsys to Make More Money From Its Software and Services, Sources Say -- WSJ

22 mrt 2026, 21:53 UTC

Winsten

Zijin Gold International Plans 59.2 Tons of Gold Production in 2026; up 12.3% on Year >2259.HK

22 mrt 2026, 21:53 UTC

Winsten

Zijin Gold International Rising Gold Prices Supported Results >2259.HK

22 mrt 2026, 21:53 UTC

Winsten

Zijin Gold International 2025 Rev $5.38B Vs. $2.99B >2259.HK

22 mrt 2026, 21:53 UTC

Winsten

Zijin Gold International 2025 Net $1.60B Vs. Net $481.37M >2259.HK

22 mrt 2026, 21:31 UTC

Winsten

China Petroleum & Chemical Plans CNY131.6B-CNY148.6B Capex Spending in 2026>0386.HK

22 mrt 2026, 21:31 UTC

Winsten

China Petroleum & Chemical: Decrease in Sales Volumes of Refined Oil Products Also Hurt Results >0386.HK

22 mrt 2026, 21:31 UTC

Winsten

China Petroleum & Chemical 2025 Results Weighed by Decrease in Prices of Petroleum, Petrochemical Products>0386.HK

22 mrt 2026, 21:31 UTC

Winsten

China Petroleum & Chemical 2025 Rev CNY2.78T Vs. CNY3.07T >0386.HK

22 mrt 2026, 21:31 UTC

Winsten

China Petroleum & Chemical 2025 Net CNY32.48B Vs. Net CNY48.94B >0386.HK

22 mrt 2026, 21:25 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Bonds Decoupling From Oil Amid Longer Conflict Fears -- Market Talk

22 mrt 2026, 21:22 UTC

Acquisities, Fusies, Overnames

St Barbara: Remarks Follow Recent Inquiries About Simberi's Fuel Stocks

22 mrt 2026, 21:21 UTC

Acquisities, Fusies, Overnames

St Barbara: Simberi Currently Uses About 65,000 Liters Per Day For Mining Fleet, Power Generation

22 mrt 2026, 21:21 UTC

Marktinformatie

Revised Fuel Subsidy Mechanism Positive for Ampol, Viva Energy -- Market Talk

22 mrt 2026, 21:21 UTC

Acquisities, Fusies, Overnames

St Barbara: Has Been Taking Precaution to Increase Diesel Storage For Several Months

Peer Vergelijking

Prijswijziging

Cencora Inc Prognose

Koersdoel

By TipRanks

25.86% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 411.44 USD  25.86%

Hoogste 440 USD

Laagste 380 USD

Gebaseerd op 10 Wall Street-analisten die 12-maands prijsdoelen bieden voor Cencora Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

10 ratings

9

Buy

1

Hold

0

Sell

Sentiment

By Acuity

147 / 350 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat